Fig. 6From: Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresisLeft panels show intense sclerotic features of cGVHD in both hands and feet. Right panel shows a nearly complete resolution after ruxolitinib treatmentBack to article page